Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages both intellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Rejoni
|
Series B | $25M | Biotechnology | Yes |
Jul 21, 2016
nVision Medical
|
Series B | $12M | Biotechnology | — |
Apr 25, 2013
nVision Medical
|
Series A | $4.14M | Biotechnology | Yes |
Dec 13, 2011
nVision Medical
|
Seed | $125K | Biotechnology | — |